Cocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza

Go back to Cocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza
Cocrystal Pharma, Inc. (NASDAQ: COCP) Delayed: 1.06 +0.06 (6.00%)
Previous Close $1.00    52 Week High $0.92 
Open $1.00    52 Week Low $0.32 
Day High $1.08    P/E N/A 
Day Low $1.01    EPS $-0.18 
Volume 132,498